In late 2021, Amber Salzman interviewed for a job that she had no intention of taking. A relatively new start-up company, called Epicrispr Biotechnologies, was looking for a chief executive, and it ...

CRISPR Therapeutics AG focuses on creating transformative medicines through its proprietary gene-editing platform. Its flagship product is CASGEVY, a therapy developed for sickle cell disease and ...

In late 2021, Amber Salzman interviewed for a job that she had no intention of taking. A relatively new start-up company, called Epicrispr Biotechnologies, was looking for a chief executive, and it ...

Lore is an open source version control system designed for unprecedented scalability of both data and teams. It is optimized for projects that combine code with large binary assets, including games ...

A vote to bar Larry Sanger indefinitely from the volunteer community of Wikipedia came days after he submitted a proposal on “intellectual diversity.” By Adeel Hassan A founder of Wikipedia who calls ...

Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

Left-leaning website Wikipedia has taken the drastic action of permanently blocking one of its founders from editing pages — after he had campaigned to make it more balanced and fair. Last month, ...

TikTok has spent years perfecting the art of knowing exactly what you want to watch next. Open the app, scroll a few times, and suddenly it’s serving videos that feel uncannily tailored to your ...

Even if you haven’t watched season one of Apple TV’s “Sugar,” you probably already know about its wacky end-of-season plot twist. Debuting in 2024, the series focuses on private investigator John ...

Check out Python’s powerful new linters and profiling tools, and learn how virtual environments can save you time and trouble. Meta’s long-awaited Pyrefly linter is out in a 1.0 version, and the ...

The technology, still far from clinical use, could one day prevent devastating diseases. But critics warn that even these early results may also fuel interest in commercial embryo editing, despite ...